Specific Interventions - Pharmacologic

Saturday, May 17, 2014: 11:30 AM-1:30 PM
Atrium Ballroom (Marriott Marquis Atlanta)
11:30 AM
140 Patterns of Psychotropic Medication Use Among Children Referred for Autism Spectrum Disorder Evaluation
I. Bukelis, F. J. Biasini, K. C. Guest, S. E. O'Kelley, A. N. Harris and A. Patel
11:30 AM
141 Modulation of the Locus Coeruleus-Noradrenergic System with Milnacipran Vs Placebo in Autism Spectrum Disorder
R. H. Noone, C. J. Ferretti, B. P. Taylor, E. Racine, J. L. Kirsch and E. Hollander
11:30 AM
142 Multi-Site Randomised Controlled Trial of Fluoxetine in Children and Adolescents with Autism (FAB): Rationale and Design
A. Mouti, M. Kohn, D. Reddihough, C. Marraffa, P. Hazell, J. Wray, K. Lee, P. J. Santosh, S. Reid, D. Dossetor, N. Silove, J. Carlin, A. Whitehouse, J. Granich, S. Kloprogge, M. O'Sullivan, F. Orsini, P. Lockhart, S. Clarke and A. Poulton
11:30 AM
143 Preliminary Investigation of Lithium for Mood Disorder Symptoms in Children with Autism Spectrum Disorder
M. Siegel, C. A. Beresford, O. Teer, M. Bunker, M. Verdi, A. Stedman and K. A. Smith